ArticlePediatric blood & cancer2020

Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium.

Douglas J Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.